Suchergebnisse - "Enomoto, Takayuki"

PubPharm (629)

81

Long-Term Effects of Human Papillomavirus Vaccination in Clinical Trials and Real-World Data : A Systematic Review

enthalten in: Vaccines | 2022

von Kurosawa, M. | Sekine, M. | Yamaguchi, M. | +9

82

Lenvatinib plus Pembrolizumab for Advanced Endometrial Cancer

enthalten in: The New England journal of medicine | 2022

von Makker, V. | Colombo, N. | Casado Herráez, A. | +122

CommentIn: Nat Rev Clin Oncol. 2022 Mar;19(3):149. - PMID 35087212

83

An artificial intelligence-assisted diagnostic system improves the accuracy of image diagnosis of uterine cervical lesions

enthalten in: Molecular and clinical oncology | 2022

von Ito, Y. | Miyoshi, A. | Ueda, Y. | +16

84

Genetic overlap analysis of endometriosis and asthma identifies shared loci implicating sex hormones and thyroid signalling pathways

enthalten in: Human reproduction (Oxford, England) | 2022

von Adewuyi, E. | Mehta, D. | International Endogene Consortium (IEC) | +66

85

The looming health hazard : A wave of HPV-related cancers in Japan is becoming a reality due to the continued suspension of the governmental recommendation of HPV vaccine

enthalten in: The Lancet regional health. Western Pacific | 2022

von Yagi, A. | Ueda, Y. | Ikeda, S. | +4

86

Efficacy and safety of standard of care with/without bevacizumab for platinum-resistant ovarian/fallopian tube/peritoneal cancer previously treated with bevacizumab : The Japanese Gynecologic Oncology Group study JGOG3023

enthalten in: Cancer science | 2022

von Shoji, T. | Enomoto, T. | Abe, M. | +10

87

Association between hospital treatment volume and survival of women with gynecologic malignancy in Japan : a JSOG tumor registry-based data extraction study

enthalten in: Journal of gynecologic oncology | 2022

von Machida, H. | Matsuo, K. | Oba, K. | +9

CommentIn: J Gynecol Oncol. 2022 Jan;33(1):e17. - PMID 34910398

88

Cellular and Humoral Immune Responses Induced by an HLA Class I-restricted Peptide Cancer Vaccine Targeting WT1 Are Associated With Favorable Clinical Outcomes in Advanced Ovarian Cancer

enthalten in: Journal of immunotherapy (Hagerstown, Md. : 1997) | 2022

von Nishida, S. | Morimoto, S. | Oji, Y. | +18

89

Efficacy and safety of standard of care with/without bevacizumab for platinum‐resistant ovarian/fallopian tube/peritoneal cancer previously treated with bevacizumab : The Japanese Gynecologic Oncology Group study JGOG3023

enthalten in: Cancer Science | 2022

von Shoji, T. | Enomoto, T. | Abe, M. | +10

90

Lenvatinib plus pembrolizumab in Japanese patients with endometrial cancer : Results from Study 309/ KEYNOTE‐775

enthalten in: Cancer Science | 2022

von Yonemori, K. | Yunokawa, M. | Ushijima, K. | +15